Mobile Menu Button
  • 03 Jan 18

Home Spirometry Is the Future of Monitoring Lung Disease Progression in LAM Patients

Home spirometry is being added as a secondary end point in a lymphangioleiomyomatosis (LAM) trial soon to begin enrollment at the University of Cincinnati (UC) Medical Center. Its inclusion is aimed at helping to assess the feasibility and reliability of performing home spirometry among patients with LAM. “Checking lung function more often will result in

Learn More →